||International Journal of Cancer Research
||Publisher: Academic Journals Inc., USA
Ethical Guidelines/Editorial Policy
| Papers must be submitted with the understanding that they have not been
published elsewhere (except in the form of an abstract or as part of a published
lecture or thesis) and are not currently under consideration by
another journal published by or any other publisher. The submitting
(corresponding) author is responsible for ensuring that the article's publication
has been approved by all the other co-authors. It is also the authors' responsibility
to ensure that the articles emanating from a particular institution are
submitted with the approval of the necessary institution. Only an acknowledgment
from the editorial office officially establishes and confirms the date of receipt. Further
correspondence and proofs will be sent to the corresponding author(s) before
publication unless otherwise indicated. It is a condition for submission
of a paper that the authors permit editing of the paper for readability.
All enquiries concerning the publication of accepted papers should be addressed
to [email protected]
Authorship is an explicit way of assigning responsibility and giving credit
for intellectual work. These both are linked together. Authorship practices should
be judged by how honestly they reflect actual contributions to the final
product. Authorship has its importantance for the reputation, academic promotion,
and grant support of the individuals involved as well as to the strength
and reputation of their institution.
Disputes sometimes arise about who should be listed as authors of an intellectual
product and the order in which they should be listed. When disagreements
over authorship arise, they can take a substantial toll on the good will,
effectiveness, and reputation of the individuals involved and their academic
community. Many such disagreements result from misunderstanding and failed
communication among colleagues and might have been prevented by a clear,
early understanding of standards for authorship that are shared by the
academic community as a whole.
International Journal of Cancer Research does not require all the authors of a research paper have to sign the letter
of submission, nor do impose an order on the list of authors. Submission
to International Journal of Cancer Research is taken by the journal to mean that all the listed authors
have agreed all of the contents. The corresponding (submitting) author
is responsible for having ensured that this agreement has been attained
and for managing all communication between the journal and all co-authors,
before and after publication. Any change to the authors list after submission,
such as a change in the order of the authors or the deletion or addition
of authors needs to be approved by a signed letter from every author.
Minimum Requirements for Authorship
All persons designated as authors should qualify for authorship, and all
those who qualify should be listed. Each author should have participated
sufficiently in the work to take public responsibility for appropriate
portions of the content. One or more authors should take responsibility
for the integrity of the work as a whole, from inception to published
Authorship credit should be based only on:
||substantial contributions to conception and design,
or acquisition of data, or analysis and interpretation of data and
||final approval of the version to be published.
Conditions a and b must meet the criteria. Acquisition of funding, the collection
of data, or general supervision of the research group, by themselves,
do not justify authorship.
Authors should provide a description of what each contributed, and editors
should publish that information. All others who contributed to the work
who are not authors should be named in the Acknowledgments, and what they
did should be described.
Minimum Requirements for Acknowledgments
List all contributors who do not meet the criteria for authorship, such
as a person who provided purely technical help, writing assistance, or
a department chair who provided only general support. Financial and material
support should also be acknowledged.
Groups of persons who have contributed materially to the paper but whose
contributions do not justify authorship may be listed under a heading
such as "clinical investigators" or "participating investigators,"
and their function or contribution should be described, e.g., "served
as scientific advisors," "critically reviewed the study proposal,"
"collected data," or "provided and cared for study".
Because readers may infer their endorsement of the data and conclusions,
all persons must have given written permission to be acknowledged.
Authors are strongly encouraged to include a statement in the end noted
to specify the actual contribution of each co-author to the completed work.
International Journal of Cancer Research allows two co-authors to be specified as having contributed equally
to the work being described. Author contribution statement should be clear
like the following example:
S.C.W., P.R.J.B., P.V.W. and I.K.T developed the concepts and also designed the
experiments. S.C.W. and S.G. performed P. infestans transformations
and plant inoculations. P.C.B. carried out confocal microscopy and
advised on cell biology. S.C.W. performed GUS assays and light microscopy.
A.O.A. and J.G.M. quantified gene expression. Antibody detection of
tagged transformants was performed by I.H. and S.C. L.M., J.G.M.,
E.M.G. and M.R.A. carried out experiments with P. atrosepticum.
L.P. conducted all the bioinformatics analyses.
International Journal of Cancer Research aims at rapid publication of high quality research while maintaining
rigorous but sympathetic peer review process. Manuscripts (other than
those that are of insufficient quality or unlikely to be competitive enough
for publication) will be peer-reviewed by two or more experts in the fields,
and a decision is returned to the authors in about one month. If due to
special circumstance, the review process takes more time, authors will
be informed by email. Manuscripts with significant results will be reviewed
and published at the highest priority and speed. Possible decisions on
a manuscript are:
• accepted as it is
• accepted after minor revision
• accepted after major revision
If minor revision is required, authors should return a revised version
as soon as possible within 15 days. If major revision is required, authors
should return a revised version within 25 days.
About Duplicate publication
Material submitted to International Journal of Cancer Research must be original and not published or
submitted for publication elsewhere. Authors submitting a contribution
to International Journal of Cancer Research who have related material under consideration or in press
elsewhere should upload a clearly marked copy at the time of submission
and draw the editor's attention to it in their cover letter. If a part
of a contribution that an author wishes to submit to International Journal of Cancer Research has appeared
or will appear elsewhere, the author must specify the details in the cover
letter. Consideration by the International Journal of Cancer Research is possible if the main result,
conclusion, or implications are not apparent from the other work, or if
there are other factors, for example if the other work is published in
a language other than English.
Author is responsible to get permission from previous publisher or copyright
holder if an author is re-using any part of paper e.g., figure(s),
published elsewhere, or that is copyrighted.
The editors consider all the materials in good faith that their journals have
full permission to publish every part of the submitted material including
Plagiarism is the use or close imitation of the language and ideas of another
author and representation of them as one's own original work. Duplicate
publication, sometimes called self-plagiarism, occurs when an author reuses
substantial parts of his or her own published work without providing the
appropriate references. This can range from getting an identical paper published
in multiple journals, where authors add small amounts of new data to a previous
Plagiarism can be said to have clearly occurred when large chunks of text
have been copied and pasted. Such manuscripts would not be considered for publication
in the Journals. But minor plagiarism without dishonest intent
is relatively frequent, for example when an author reuses parts of an introduction
from an earlier paper. The editors will judge any case of which they become
aware (either by their own knowledge of and reading about the literature,
or when alerted by referees) on its own merits.
If a case of plagiarism comes to light after a paper is published in International Journal of Cancer Research
, the journal will conduct a preliminary investigation. If plagiarism is
found, the journal will contact the author's institute and funding agencies.
A determination of misconduct will lead the Journal to run
a statement, bidirectionally linked online to and from the original paper,
to note the plagiarism and to provide a reference to the plagiarized material.
The paper containing the plagiarism will also be obviously marked on each
page of the PDF. Depending on the extent of the plagiarism, the paper may
also be formally retracted.
Material published by the author before submission in the following categories is considered prior publication: 1) articles published in any publication, even online-only, non-peer-reviewed publications, such as Nature Proceedings or the physics arXiv 2) articles, book chapters, and long abstracts containing original data in figures and tables, especially in proceedings publications as well as posters containing original data disseminated beyond meeting attendees, e.g., displayed in websites such as that maintained by F1000; 3) widely circulated, copyrighted, or archival reports, such as the technical reports of IBM, the preliminary reports of MIT, the institute reports of the US Army, or the internal reports of NASA.
Doctoral dissertations that are made available by UMI/ProQuest or institutional repositories are not considered prior publication. Data portions of submitted papers that have appeared on a website will be permitted; with the provison that the author informs the Editor at the time of the submission that such material exists so that the Editor can determine the suitability of such material for publication. Failure to do so will result in an automatic rejection of the manuscript. Examples of such work include, but are not limited to, immuno-fluorescence micrographs and/or animated gif/video files posted on a website, or NIH-mandated posting of DNA microarray data. After the article is published in International Journal of Cancer Research, the data should be removed from the author’s website.
Authors with concerns about possible prior publication that does not fall clearly into one of these categories should contact the Editorial Office of International Journal of Cancer Research and forward the material for examination.
Once you have submitted your manuscript to International Journal of Cancer Research, we ask that you not subsequently post this manuscript, or a revised version of it, to a preprint server. However, if your manuscript receives a final rejected decision at International Journal of Cancer Research or if you withdraw it from editorial consideration at International Journal of Cancer Research, this restriction is then lifted.
Science Alert reviewers have a responsibility to report suspected duplicate publication, fraud, plagiarism, or concerns about animal or human experimentation to the Editor. A reviewer may recognize and report that he/she is refereeing, or has recently refereed, a similar or identical paper for another journal by the same author(s). Readers may report that they have seen the same article elsewhere, or authors may see their own published work being plagiarized. In all cases we address ethical concerns diligently following an issue-specific standard practice as summarized below.
The first action of the journal Editor is to inform the Editorial Office of Science Alert by supplying copies of 1) the relevant material and 2) a draft letter to the corresponding author asking for an explanation in a nonjudgmental manner. The Editorial Office must approve any correspondence before it is sent to the author. If the author’s explanation is unacceptable and it seems that serious unethical conduct has taken place, the matter is referred to the Publication Committee via Editorial Office. After deliberation, the Committee will decide whether the case is sufficiently serious to warrant a ban on future submissions to, and serving as a reviewer for, Science Alert Journals; and/or whether the offending author’s institution should be informed. The decision has to be approved by the Executive Cabinet of the Science Alert Council, and the author has the right to appeal a sanction, with the opportunity to present his/her position.
If the infraction is less severe, the Editor, upon the advice of the Publication Committee, will send the author a letter of reprimand and remind the author of Science Alert publication policies; if the manuscript has been published, the Editor may require the author to publish an apology in the journal to correct the record. If, through the author’s actions, Science Alert has violated the copyright of another journal, the Publication Committee writes a letter of apology to the other journal.
In serious cases of fraud that result in retraction of the article, a retraction notice will be published in the journal and will be linked to the article in the online version. The online version will also be marked “retracted” with the retraction date.